Patents Assigned to Genitrix, Ltd.
  • Vaccine compositions and methods of modulating immune responses
    Patent number: 6224870
    Abstract: The invention provides compositions and methods for modulating immune responses in subjects. The invention is based, at least in part, on the discovery that an in-frame translation fusion of an antigen with an APC binding domain of an opsonin forms a molecule, that is, a fusion polypeptide, which when administered to a subject modulates an immune response to the antigen.
    Type: Grant
    Filed: January 15, 1998
    Date of Patent: May 1, 2001
    Assignee: Genitrix, Ltd.
    Inventor: Andrew H. Segal